Tenofovir vs. Entecavir after treatment for HBV-associated HCC

Published Date: 08 Mar 2023

This review compared the effectiveness of entecavir and tenofovir in reducing relapses and mortality after treatment for HBV-related hepatocellular carcinoma.

Read Full News

Latest News

Review Reproductive Health Regularly With CF Patients

Recent research emphasizes the safety of contraception and greater potential for pregnancy.

A Single US Measles Outbreak Can Cost Millions of Dollars, Study Estimates

The overall cost of containing a 2025 measles outbreak in New Mexico was nearly $5.4 million, a new study estimates.

Infants Face Higher Risks for Common Respiratory Infections

Infants face higher risks for respiratory infections requiring medical care than older children, although many infections remain asymptomatic or are mostly managed at home.

Cyclosporiasis Cases in Michigan Rise to 10,773 in Ongoing Outbreak

Michigan reported 10,773 cases linked to a cyclosporiasis outbreak on Friday, up 387 from the previous day, the ⁠state health department said in its latest...

Finland Detects African Swine Fever for First Time

Finland has detected African swine fever for the first time after ⁠laboratory tests found the virus in three wild boar piglets in eastern Finland, ⁠the Finnish Food...

Congo's Ebola Outbreak Started At Least in January, Report Shows

Democratic Republic of Congo's fast-spreading Ebola outbreak started in January, or even earlier, in the ⁠eastern Ituri province, a report published in the journal Science...

Todays Updates

Dual Checkpoint Blockade Boosts Breast Cancer pCR

Patients with high-risk ERBB2-negative breast cancer receive dual checkpoint blockade with cemiplimab and fianlimab in addition to standard neoadjuvant chemotherapy.

Todays Updates

Dual Checkpoint Blockade Boosts Breast Cancer pCR

Patients with high-risk ERBB2-negative breast cancer receive dual checkpoint blockade with cemiplimab and fianlimab in addition to standard neoadjuvant chemotherapy.

Latest News

Recent research emphasizes the safety of contraception and greater potential for pregnancy.

The overall cost of containing a 2025 measles outbreak in New Mexico was nearly $5.4 million, a new study estimates.

Infants face higher risks for respiratory infections requiring medical care than older children, although many infections remain asymptomatic or are mostly managed at home.

Michigan reported 10,773 cases linked to a cyclosporiasis outbreak on Friday, up 387 from the previous day, the ⁠state health department said in its latest...

Finland has detected African swine fever for the first time after ⁠laboratory tests found the virus in three wild boar piglets in eastern Finland, ⁠the Finnish Food...

Democratic Republic of Congo's fast-spreading Ebola outbreak started in January, or even earlier, in the ⁠eastern Ituri province, a report published in the journal Science...

News All Time

US FDA Widens Investigation Into Cyclosporiasis Cases to Four More States

The U.S. FDA and the CDC are widening their investigation into a cyclosporiasis outbreak linked to shredded iceberg lettuce from central Mexico after identifying ⁠cases in...

Nearly 3,000 Confirmed Infected With Ebola in Congo After Data Review

The number of people confirmed infected with Ebola in the Democratic ⁠Republic of Congo was heading towards 3,000 on Friday after officials reviewed data ⁠in two of the...

Merck Licenses Experimental HIV Pill to Generic Makers in 129 Countries

Merck said on Friday it signed seven voluntary licensing agreements with generic drug manufacturers to make and sell ⁠lower-cost versions of its experimental once-monthly...

Patients Are Self-Prescribing DoxyPEP. Is This a Problem?

Syphilis cases are rising across Europe. Many are turning to doxycycline to prevent it. Is antimicrobial resistance a concern?

Pfizer's Prostate Cancer Drug Combination Gets US FDA Priority Review

Pfizer said on Wednesday the U.S. Food and Drug Administration had granted priority review to ⁠its application seeking expanded approval for its prostate cancer treatment...

Proton Pump Inhibitors Boost Exacerbations in Bronchiectasis

Consider a deprescribing trial in patients without chronic indications.

Expected Practice Guidelines Boost Oral/IV Antibiotic Use

Expected practice guidelines increase oral or long-acting intravenous antibiotic use and lower readmission rates, study shows.

Carl H. June on CAR-T’s Next Frontier: Autoimmune Disease

In an interview, Carl H. June discusses how CAR-T therapy transformed blood cancer treatment, the challenges of extending it to solid tumors, and why autoimmune disease may be its next major frontier.

US Cyclosporiasis Cases Top 4,100 as CDC Investigates Lettuce-linked Outbreak

The Centers for Disease Control and Prevention has pegged the number of domestically acquired, lab-confirmed U.S. cyclosporiasis cases ⁠since May 1 at 4,173 after federal...

Congo Says Nearly 1,000 Die Of Ebola, Confirmed Cases Rise to 2,473

The ⁠number of confirmed Ebola ⁠cases in the ⁠Democratic Republic ‌of Congo has increased to 2,473, including ‌999 deaths, government data showed ‌on...

Kids Born in Lockdown Show Lower Executive Function at Age 4

Kids born in the first COVID lockdown in England show age-appropriate language and motor skills, but executive function remains the key area of concern at age 4 and may need extra support at school.

Cyclosporiasis Cases in Michigan Climb to Over 7,000, State Health Officials Say

Michigan health officials reported 7,171 cases linked to an outbreak of cyclosporiasis on Wednesday, up 600 cases since its ⁠last update on Tuesday.

Fewer Children Got US-backed HIV Treatment After Aid Cuts, Study Finds

(Refiles to add missing byline)

Gilead, Merck Weekly HIV Pill Keeps Virus Suppressed in Late-stage Trials

Gilead Sciences and Merck said on Tuesday their experimental once-weekly HIV pill kept the virus suppressed in ⁠two late-stage trials, supporting regulatory filings for what...

Cyclosporiasis Surge: A Clinician's Quick Guide

With a 34-state Cyclospora outbreak driving GI visits, Dr Levy breaks down diagnosis, testing pitfalls, and treatment clinicians need to know.

US FDA Says False-positive Lettuce Test Doesn't Change Taylor Farms Cyclospora Probe

The U.S. Food and Drug Administration on Monday defended publicizing a lettuce sample later found to be ⁠a false positive for cyclospora, saying the reversal does not...

Recommended News For You

PSMA-PET/CT Detects Metastatic Prostate Cancer Missed by Other Imaging

AI-Driven Biomarker Predicts Prostate Cancer Outcomes

Infection Burden High With Myeloma T-Cell Therapies

Tafasitamab Regimen Improves PFS in Relapsed/Refractory Follicular Lymphoma

Both men and women who receive the HPV vaccine have a lower risk of developing multiple cancer types.

Global inequalities found in cancer research funding

Neural networks and label-free microscopy enable accurate detection of pancreatic tumors

Recommended Articles For You

Understanding Abemaciclib: A Breakthrough Treatment for Breast Cancer  

Radiation Oncology: Integrating AI, Theranostics, and Adaptive Therapies for Personalized Cancer Care 

The Importance of Understanding Your D-Dimer Levels: A Comprehensive Guide 

Unlocking the Secrets of Squamous Cell Carcinoma: New Hope for Patients 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Non-Factor Therapies in Hemophilia: Cutting-Edge Approaches to Individualize Care

2.

Finding a clue to the origin of treatment-resistant leukemia in kids

3.

New CAR-T Drug Induces Durable Remissions in ALL, Published Data Show

4.

Have the Harms of Lung Cancer Screening Been Exaggerated?

5.

Study suggests exercise could reduce breast cancer recurrence

1.

Leukemia: Understanding the Disease and Its Impact on Patients 

2.

Surgery for Tracheoesophageal Fistula: What to Expect Before, During, and After 

3.

Unlocking the Secret to Accurate ANC Calculation with This Informative Blog Post

4.

Strategic Breakthroughs in Oncology in Clinical Decision-Making

5.

Clinical Frameworks in Oncology and Quality Improvement

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

Asian Symposium on Advancement in Hematology and Oncology

4.

International Cancer Conference

1.

Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part V

2.

Navigating the Complexities of Ph Negative ALL - Part II

3.

Post Progression Approaches After First-line Third-Generaion ALK Inhibitors

4.

Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part II

5.

Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part V

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot